LBT Innovations Ltd is an Australian developer of clinical and diagnostic technology. Based in Adelaide, South Australia, the Company was formed in 2004 and listed on the Australian Securities Exchange in July 2006 (ASX: LBT).

In April 2007, LBT Innovations signed an agreement with world-leading, clinical diagnostic company bioMérieux for the commercialisation of its MicroStreak^® technology.The first application of the technology was launched in late 2008 across the global pathology markets and is marketed by bioMerieux as the PREVI Isola.

LBT Innovations plans to progress the development of its MicroStreak^® technology into other markets, while leveraging existing relationships to build a new technology pipeline for future growth. The Company’s mission is to become a global leader in innovative automation technologies for medical and scientific laboratories.

LATEST NEWS

ASX Announcement
LBT Half-Year Results

Media
Boardroom Radio interview, 8/2/10